Literature DB >> 31637427

Mosaicism for KCNJ5 Causing Early-Onset Primary Aldosteronism due to Bilateral Adrenocortical Hyperplasia.

Andrea G Maria1, Mari Suzuki1,2, Annabel Berthon1, Crystal Kamilaris1, Andrew Demidowich1, Justin Lack3,4, Mihail Zilbermint1,5,6, Fady Hannah-Shmouni1, Fabio R Faucz1, Constantine A Stratakis1.   

Abstract

BACKGROUND: Somatic variants in KCNJ5 are the most common cause of primary aldosteronism (PA). There are few patients with PA in whom the disease is caused by germline variants in the KCNJ5 potassium channel gene (familial hyperaldosteronism type III-FH-III).
METHODS: A 5-year-old patient who developed hypertension due to bilateral adrenocortical hyperplasia (BAH) causing PA had negative peripheral DNA testing for any known genetic causes of PA. He was treated medically with adequate control of his PA but by the third decade of his life, due to worsening renal function, he underwent bilateral adrenalectomy.
RESULTS: Focused exome sequencing in multiple nodules of his BAH uncovered a "hot-spot" pathogenic KCNJ5 variant, while repeated Sanger sequencing showed no detectable DNA defects in peripheral blood and other tissues. However, whole exome, "deep" sequencing revealed that 0.23% of copies of germline DNA did in fact carry the same KCNJ5 variant that was present in the adrenocortical nodules, suggesting low level germline mosaicism for this PA-causing KCNJ5 defect.
CONCLUSIONS: Thus, this patient represents a unique case of BAH due to a mosaic KCNJ5 defect. Undoubtedly, his milder PA compared with other known cases of FH-III, was due to his mosaicism. This case has a number of implications for the prognosis, treatment, and counseling of the many patients with PA due to BAH that are seen in hypertension clinics. © American Journal of Hypertension, Ltd 2019. All rights reserved. For Permissions, please email: journals.permissions@oup.com.

Entities:  

Keywords:  zzm321990 KCNJ5zzm321990 ; blood pressure; familial hyperaldosteronism; genetics; hyperaldosteronism; hypertension; mosaicism; primary aldosteronism

Mesh:

Substances:

Year:  2020        PMID: 31637427      PMCID: PMC8204147          DOI: 10.1093/ajh/hpz172

Source DB:  PubMed          Journal:  Am J Hypertens        ISSN: 0895-7061            Impact factor:   3.080


  25 in total

Review 1.  Carney complex and McCune Albright syndrome: an overview of clinical manifestations and human molecular genetics.

Authors:  Paraskevi Salpea; Constantine A Stratakis
Journal:  Mol Cell Endocrinol       Date:  2013-09-05       Impact factor: 4.102

Review 2.  Mosaicism and clinical genetics.

Authors:  Nancy B Spinner; Laura K Conlin
Journal:  Am J Med Genet C Semin Med Genet       Date:  2014-11-25       Impact factor: 3.908

3.  Somatic HIF2A gain-of-function mutations in paraganglioma with polycythemia.

Authors:  Zhengping Zhuang; Chunzhang Yang; Felipe Lorenzo; Maria Merino; Tito Fojo; Electron Kebebew; Vera Popovic; Constantine A Stratakis; Josef T Prchal; Karel Pacak
Journal:  N Engl J Med       Date:  2012-09-06       Impact factor: 91.245

4.  A novel genetic locus for low renin hypertension: familial hyperaldosteronism type II maps to chromosome 7 (7p22).

Authors:  A R Lafferty; D J Torpy; M Stowasser; S E Taymans; J P Lin; P Huggard; R D Gordon; C A Stratakis
Journal:  J Med Genet       Date:  2000-11       Impact factor: 6.318

5.  A case of severe hyperaldosteronism caused by a de novo mutation affecting a critical salt bridge Kir3.4 residue.

Authors:  Silvia Monticone; Sascha Bandulik; Julia Stindl; Mihail Zilbermint; Ivan Dedov; Paolo Mulatero; Michael Allgaeuer; Chyi-Chia Richard Lee; Constantine A Stratakis; Tracy A Williams; Anatoly Tiulpakov
Journal:  J Clin Endocrinol Metab       Date:  2015-01       Impact factor: 5.958

Review 6.  Somatic mosaicism: implications for disease and transmission genetics.

Authors:  Ian M Campbell; Chad A Shaw; Pawel Stankiewicz; James R Lupski
Journal:  Trends Genet       Date:  2015-04-21       Impact factor: 11.639

7.  Targeted Molecular Characterization of Aldosterone-Producing Adenomas in White Americans.

Authors:  Kazutaka Nanba; Kei Omata; Tobias Else; Peter C C Beck; Aya T Nanba; Adina F Turcu; Barbra S Miller; Thomas J Giordano; Scott A Tomlins; William E Rainey
Journal:  J Clin Endocrinol Metab       Date:  2018-10-01       Impact factor: 5.958

Review 8.  An Update on Familial Hyperaldosteronism.

Authors:  H E Korah; U I Scholl
Journal:  Horm Metab Res       Date:  2015-10-07       Impact factor: 2.936

9.  Molecular Heterogeneity in Aldosterone-Producing Adenomas.

Authors:  Kazutaka Nanba; Andrew X Chen; Kei Omata; Michelle Vinco; Thomas J Giordano; Tobias Else; Gary D Hammer; Scott A Tomlins; William E Rainey
Journal:  J Clin Endocrinol Metab       Date:  2016-01-14       Impact factor: 5.958

10.  Germline, hematopoietic, mosaic, and somatic variation: interplay between inherited and acquired genetic alterations in disease assessment.

Authors:  Eric Q Konnick; Colin C Pritchard
Journal:  Genome Med       Date:  2016-10-05       Impact factor: 11.117

View more
  14 in total

Review 1.  Adrenocortical tumorigenesis: Lessons from genetics.

Authors:  Crystal D C Kamilaris; Fady Hannah-Shmouni; Constantine A Stratakis
Journal:  Best Pract Res Clin Endocrinol Metab       Date:  2020-05-23       Impact factor: 4.690

Review 2.  Update on the Genetics of Primary Aldosteronism and Aldosterone-Producing Adenomas.

Authors:  Georgia Pitsava; Fabio R Faucz; Constantine A Stratakis; Fady Hannah-Shmouni
Journal:  Curr Cardiol Rep       Date:  2022-07-16       Impact factor: 3.955

Review 3.  Pathophysiology of bilateral hyperaldosteronism.

Authors:  Kazutaka Nanba; William E Rainey
Journal:  Curr Opin Endocrinol Diabetes Obes       Date:  2022-06-01       Impact factor: 3.626

Review 4.  Genetic Alterations in Benign Adrenal Tumors.

Authors:  Georgia Pitsava; Constantine A Stratakis
Journal:  Biomedicines       Date:  2022-04-30

5.  Familial Hyperaldosteronism Type 3 with a Rapidly Growing Adrenal Tumor: An In Situ Aldosterone Imaging Study.

Authors:  Nae Takizawa; Susumu Tanaka; Koshiro Nishimoto; Yuki Sugiura; Makoto Suematsu; Chisato Ohe; Haruyuki Ohsugi; Yosuke Mizuno; Kuniaki Mukai; Tsugio Seki; Kenji Oki; Celso E Gomez-Sanchez; Tadashi Matsuda
Journal:  Curr Issues Mol Biol       Date:  2021-12-28       Impact factor: 2.976

6.  Cushing Syndrome in a Pediatric Patient With a KCNJ5 Variant and Successful Treatment With Low-dose Ketoconazole.

Authors:  Christina Tatsi; Andrea G Maria; Cole Malloy; Lin Lin; Edra London; Nick Settas; Chelsi Flippo; Meg Keil; Fady Hannah-Shmouni; Dax A Hoffman; Constantine A Stratakis
Journal:  J Clin Endocrinol Metab       Date:  2021-05-13       Impact factor: 5.958

7.  Somatic mutations of GNA11 and GNAQ in CTNNB1-mutant aldosterone-producing adenomas presenting in puberty, pregnancy or menopause.

Authors:  Junhua Zhou; Elena A B Azizan; Claudia P Cabrera; Fabio L Fernandes-Rosa; Sheerazed Boulkroun; Giulia Argentesi; Emily Cottrell; Laurence Amar; Xilin Wu; Sam O'Toole; Emily Goodchild; Alison Marker; Russell Senanayake; Sumedha Garg; Tobias Åkerström; Samuel Backman; Suzanne Jordan; Satyamaanasa Polubothu; Daniel M Berney; Anna Gluck; Kate E Lines; Rajesh V Thakker; Antoinette Tuthill; Caroline Joyce; Juan Pablo Kaski; Fiona E Karet Frankl; Lou A Metherell; Ada E D Teo; Mark Gurnell; Laila Parvanta; William M Drake; Eva Wozniak; David Klinzing; Jyn Ling Kuan; Zenia Tiang; Celso E Gomez Sanchez; Per Hellman; Roger S Y Foo; Charles A Mein; Veronica A Kinsler; Peyman Björklund; Helen L Storr; Maria-Christina Zennaro; Morris J Brown
Journal:  Nat Genet       Date:  2021-08-12       Impact factor: 41.307

8.  Transcriptomic uniqueness and commonality of the ion channels and transporters in the four heart chambers.

Authors:  Sanda Iacobas; Bogdan Amuzescu; Dumitru A Iacobas
Journal:  Sci Rep       Date:  2021-02-02       Impact factor: 4.379

Review 9.  Molecular Genetic and Genomic Alterations in Cushing's Syndrome and Primary Aldosteronism.

Authors:  Crystal D C Kamilaris; Constantine A Stratakis; Fady Hannah-Shmouni
Journal:  Front Endocrinol (Lausanne)       Date:  2021-03-12       Impact factor: 5.555

Review 10.  Update on Genetics of Primary Aldosteronism.

Authors:  Kiyotaka Itcho; Kenji Oki; Haruya Ohno; Masayasu Yoneda
Journal:  Biomedicines       Date:  2021-04-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.